Should thrombolysis be given to a stroke patient refusing therapy due to profound anosognosia?
Katz
Jeffrey M
JM
Department of Neurology and Neuroscience, New York Presbyterian Hospital-Weill Medical Center of Cornell University, 520 East 68th Street, F-610, New York, NY 10021, USA. drjmk@yahoo.com
Segal
Alan Z
AZ
D000368:Aged; D000377:Agnosia / Q000209:etiology* / Q000523:psychology; D001925:Brain Damage, Chronic / Q000209:etiology; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000150:complications / Q000523:psychology* / Q000628:therapy*; D007258:Informed Consent / Q000941:ethics*; D016743:Mental Competency; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D015912:Thrombolytic Therapy / Q000941:ethics* / Q000523:psychology; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D016312:Treatment Refusal
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator